BeOne Medicines (ONC) Enterprise Value (2016 - 2025)
Historic Enterprise Value for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to -$4.0 billion.
- BeOne Medicines' Enterprise Value fell 4940.67% to -$4.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 billion, marking a year-over-year decrease of 4940.67%. This contributed to the annual value of -$2.6 billion for FY2024, which is 1723.13% up from last year.
- As of Q3 2025, BeOne Medicines' Enterprise Value stood at -$4.0 billion, which was down 4940.67% from -$2.8 billion recorded in Q2 2025.
- BeOne Medicines' Enterprise Value's 5-year high stood at -$2.5 billion during Q1 2025, with a 5-year trough of -$6.6 billion in Q4 2021.
- Moreover, its 5-year median value for Enterprise Value was -$3.8 billion (2023), whereas its average is -$3.9 billion.
- As far as peak fluctuations go, BeOne Medicines' Enterprise Value soared by 3862.71% in 2023, and later crashed by 4940.67% in 2025.
- BeOne Medicines' Enterprise Value (Quarter) stood at -$6.6 billion in 2021, then skyrocketed by 31.47% to -$4.5 billion in 2022, then rose by 30.0% to -$3.2 billion in 2023, then grew by 17.23% to -$2.6 billion in 2024, then crashed by 53.64% to -$4.0 billion in 2025.
- Its Enterprise Value stands at -$4.0 billion for Q3 2025, versus -$2.8 billion for Q2 2025 and -$2.5 billion for Q1 2025.